A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276...

Por Cassaday, Ryan D., Goy, Andre, Advani, Suresh, Chawla, Purvi, Nachankar, Rajesh, Gandhi, Mansi, Gopal, Ajay K.
Publicado no Clin Lymphoma Myeloma Leuk (2015)

Perioperative haemostasis with full‐length, PEGylated, recombinant factor VIII with extended half‐life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single‐arm phase III trial

Por Gruppo, Ralph, López‐Fernández, Maria‐Fernanda, Wynn, Tung T., Engl, Werner, Sharkhawy, Marlies, Tangada, Srilatha
Publicado no Haemophilia (2019)

Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact...

Por Probert, Christopher SJ, Sebastian, Shaji, Gaya, Daniel R, Hamlin, P John, Gillespie, Gillian, Rose, Anita, Tate, Helen, Wheeler, Colin, Irving, Peter M
Publicado no BMJ Open Gastroenterol (2018)

A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants

Por Afolabi, Muhammed O., Ndure, Jorjoh, Drammeh, Abdoulie, Darboe, Fatoumatta, Mehedi, Shams-Rony, Rowland-Jones, Sarah L., Borthwick, Nicola, Black, Antony, Ambler, Gwen, John-Stewart, Grace C., Reilly, Marie, Hanke, Tomáš, Flanagan, Katie L.
Publicado em 2013

Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.

Por Chetan E Chitnis, Paushali Mukherjee, Shantanu Mehta, Syed Shams Yazdani, Shikha Dhawan, Ahmad Rushdi Shakri, Rukmini Bhardwaj, Puneet Kumar Gupta, Dhiraj Hans, Suman Mazumdar, Bijender Singh, Sanjeev Kumar, Gaurav Pandey, Varsha Parulekar, Nathalie Imbault, Preethi Shivyogi, Girish Godbole, Krishna Mohan, Odile Leroy, Kavita Singh, Virander S Chauhan
Publicado em 2015-01-01

Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175

Por Chitnis, Chetan E., Mukherjee, Paushali, Mehta, Shantanu, Yazdani, Syed Shams, Dhawan, Shikha, Shakri, Ahmad Rushdi, Bharadwaj, Rukmini, Gupta, Puneet Kumar, Hans, Dhiraj, Mazumdar, Suman, Singh, Bijender, Kumar, Sanjeev, Pandey, Gaurav, Parulekar, Varsha, Imbault, Nathalie, Shivyogi, Preethi, Godbole, Girish, Mohan, Krishna, Leroy, Odile, Singh, Kavita, Chauhan, Virander S.
Publicado no PLoS One (2015)

Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Na(v)1...

Por de Greef, Bianca T. A., Merkies, Ingemar S. J., Geerts, Margot, Faber, Catharina G., Hoeijmakers, Janneke G. J.
Publicado no Trials (2016)

A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine

Por Leong, F. Joel, Jain, Jay Prakash, Feng, Yiyan, Goswami, Budhaditya, Stein, Daniel S.
Publicado no Malar J (2018)

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer

Por De Boer, Richard H., Kotasek, Dusan, White, Shane, Koczwara, Bogda, Mainwaring, Paul, Chan, Arlene, Melara, Rebeca, Ye, Yining, Adewoye, Adeboye H., Sikorski, Robert, Kaufman, Peter A.
Publicado em 2012

Phase I/II Trial of the Anti-HIV Activity of Mifepristone in HIV-Infected Subjects ACTG 5200

Por Para, Michael F., Schouten, Jeff, Rosenkranz, Susan L., Yu, Song, Weiner, David, Tebas, Pablo, White, C. Jo, Reeds, Dominic, Lertora, Juan, Patterson, Kristine B., Daar, Eric S., Cavert, Wintson, Brizz, Barbara
Publicado em 2010

Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia

Por Flinn, Ian W., Gribben, John G., Dyer, Martin J. S., Wierda, William, Maris, Michael B., Furman, Richard R., Hillmen, Peter, Rogers, Kerry A., Iyer, Swaminathan Padmanabhan, Quillet-Mary, Anne, Ysebaert, Loic, Walter, Harriet S., Verdugo, Maria, Klein, Christian, Huang, Huang, Jiang, Yanwen, Lozanski, Gerard, Pignataro, Daniela Soriano, Humphrey, Kathryn, Mobasher, Mehrdad, Kipps, Thomas J.
Publicado no Blood (2019)

Phase I Clinical Trial of Valacyclovir and Standard of Care Cyclophosphamide in Children With Endemic Burkitt Lymphoma in Malawi

Por Olson, Dan, Gulley, Margaret L., Tang, Weihua, Wokocha, Clifford, Mechanic, Oren, Hosseinipour, Mina, Gold, Stuart H., Nguluwe, Nelson, Mwansambo, Charles, Shores, Carol
Publicado em 2012

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

Por Morse, Michael A, Garst, Jennifer, Osada, Takuya, Khan, Shubi, Hobeika, Amy, Clay, Timothy M, Valente, Nancy, Shreeniwas, Revati, Sutton, Mary Ann, Delcayre, Alain, Hsu, Di-Hwei, Le Pecq, Jean-Bernard, Lyerly, H Kim
Publicado em 2005

Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial

Por Qi Mei, Xiaoyu Li, Runkun Wang, Kai Qin, Yi Cheng, Weiting Cheng, Youhong Dong, Zhen He, Jun Li, Ming Li, Xi Tang, Xudong Wang, Xuxuan Xiao, Bin Yang, Yajuan Zhou, Rui Wang, Qiao Huang, Guangyuan Hu, Jian Li
Publicado em 2022-04-01

ACTR-15. SAFETY AND PRELIMINARY ACTIVITY OF PT2385, A FIRST-IN-CLASS HIF2-ALPHA INHIBITOR, PLANNED INTERIM ANALYSIS OF AN OPEN LABEL, SINGLE-ARM PHASE II STUDY IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Por Strowd, Roy, Ellingson, Benjamin, Wen, Patrick, Ahluwalia, Manmeet, Piotrowski, Anna, Desai, Arati, Clarke, Jennifer, Lieberman, Frank, Desideri, Serena, Nabors, L Burt, Grossman, Stuart
Publicado no Neuro Oncol (2018)

Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment...

Por Arndtz, Katherine, Corrigan, Margaret, Rowe, Anna, Kirkham, Amanda, Barton, Darren, Fox, Richard P, Llewellyn, Laura, Athwal, Amrita, Wilkhu, Manpreet, Chen, Yung-Yi, Weston, Chris, Desai, Amisha, Adams, David H, Hirschfield, Gideon M
Publicado no BMJ Open (2017)

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus...

Por Nakayama, Goro, Ishigure, Kiyoshi, Yokoyama, Hiroyuki, Uehara, Keisuke, Kojima, Hiroshi, Ishiyama, Akiharu, Hayashi, Naomi, Takano, Nao, Hattori, Norifumi, Kobayashi, Daisuke, Tanaka, Chie, Hayashi, Masamichi, Kanda, Mitsuro, Yamada, Suguru, Sugimoto, Hiroyuki, Koike, Masahiko, Fujiwara, Michitaka, Fujii, Tsutomu, Murotani, Kenta, Ando, Yuichi, Kodera, Yasuhiro
Publicado no BMC Cancer (2017)

Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety...

Por Koonrungsesomboon, Nut, Ngamphaiboon, Nuttapong, Townamchai, Natavudh, Teeyakasem, Pimpisa, Charoentum, Chaiyut, Charoenkwan, Pimlak, Natesirinilkul, Rungrote, Sathitsamitphong, Lalita, Ativitavas, Touch, Chaiyawat, Parunya, Klangjorhor, Jeerawan, Hongeng, Suradej, Pruksakorn, Dumnoensun
Publicado no BMC Cancer (2020)

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol

Por Combs, Stephanie E, Heeger, Steffen, Haselmann, Renate, Edler, Lutz, Debus, Jürgen, Schulz-Ertner, Daniela
Publicado em 2006

Experience with Relatox® in the combination therapy of arm and hand spasticity after stroke

Por V. V. Gusev, O. A. Lvova, T. V. Balueva
Publicado em 2017-11-01